Last reviewed · How we verify

NCT03251781

Minimal Important Difference for the Glittre-ADL Test and London Chest Activity of Daily Living Scale

Completed NA Last updated 7 September 2018
What this trial tests

NA trial testing Pulmonary Rehabilitation in Pulmonary Disease, Chronic Obstructive in 77 participants. Completed in 30 November 2017.

Timeline
1 April 2013
Primary endpoint
31 May 2017
30 November 2017

Quick facts

Lead sponsorUniversity of the State of Santa Catarina
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment77
Start date1 April 2013
Primary completion31 May 2017
Estimated completion30 November 2017
Sites2 locations across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of the State of Santa Catarina

Who can join

Adults 40 to 80, any sex, with Pulmonary Disease, Chronic Obstructive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: The ability to perform activities of daily living (ADL) in patients with chronic obstructive pulmonary disease is often impaired. Glittre-ADL Test has been used to assess limitations in ADL, and it seems to be responsive to intervention. However, the minimal detectable change for Glittre-ADL Test remains unknown. Design: Non-controlled before and after study. Setting: The study will be conducted in an outpatient pulmonary rehabilitation program in Florianopolis, Brazil. Subjects: Patients with COPD (GOLD II-IV). Interventions: Pulmonary rehabilitation program based on physical training, conducted over 24 sessions supervised, three times a week, including aerobic training in treadmill and localized training for upper limbs and lower limbs. Main measures: Glittre ADL-Test performance, six-minute walk test performance, London Chest Activity of Daily Living score, Modified Medical Research Council score, COPD Assessment Test score, Saint George Respiratory Questionnaire score before and after the pulmonary rehabilitation program.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Minimal important difference for London Chest Activity of Daily Living scale in patients with chronic obstructive pulmonary disease.
    Almeida Gulart A, de Araujo CLP, Bauer Munari A, Schneider BF, et al · · 2020 · cited 18× · PMID 32026830 · DOI 10.1016/j.physio.2019.08.007
  2. The minimal important difference for Glittre-ADL test in patients with chronic obstructive pulmonary disease.
    Gulart AA, Araujo CLP, Munari AB, Santos KD, et al · · 2020 · cited 18× · PMID 30497829 · DOI 10.1016/j.bjpt.2018.11.009

Verify or expand the search:

Other trials of Pulmonary Rehabilitation

Trials testing the same drug.

Other recruiting trials for Pulmonary Disease, Chronic Obstructive

Currently open trials in the same condition.

Other University of the State of Santa Catarina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03251781.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing